Zanolimumab (HuMax-CD4®), a fully human monoclonal antibody in clinical development for cutaneous T-cell lymphoma. Hematology Meeting Reports, [S. l.], v. 2, n. 5, 2009. DOI: 10.4081/hmr.v2i5.736. Disponível em: https://journals.pagepress.net/hmr/article/view/736. Acesso em: 22 apr. 2026.